Cerebral Glucose Hypometabolism in Neurodegeneration

📖 Wiki Page

mechanism1286 wordssynced 2026-04-02

VIM Protein (Vimentin)

Introduction

Cerebral Glucose Hypometabolism In Neurodegeneration represents a key pathological mechanism in neurodegenerative diseases. This page explores the molecular and cellular processes involved, their contribution to disease progression, and therapeutic implications.

<div class="infobox infobox-protein">
<table>
<tr><th>Protein Name</th><td>VIM (Vimentin)</td></tr>
<tr><th>Gene</th><td>[VIM](/proteins/vim-protein)</td></tr>
<tr><th>UniProt ID</th><td>[P08670](https://www.uniprot.org/uniprotkb/P08670)</td></tr>
<tr><th>PDB ID</th><td>1GK4, 3KLT, 4YV3</td></tr>
<tr><th>Molecular Weight</th><td>54 kDa (466 amino acids)</td></tr>
<tr><th>Subcellular Localization</th><td>Cytoplasm, intermediate filaments, perinuclear region</td></tr>
<tr><th>Protein Family</th><td>Type III intermediate filament family</td></tr>
<tr><th>Brain Expression</th><td>Neurons, astrocytes, oligodendrocytes, microglia</td></tr>
<tr><th>Associated Diseases</th><td>[Alzheimer's Disease](/diseases/alzheimers-disease), [Parkinson's Disease](/diseases/parkinsons-disease), [ALS](/diseases/amyotrophic-lateral-sclerosis), Multiple Sclerosis</td></tr>
</table>
</div>

Overview

...

VIM Protein (Vimentin)

Introduction

Overview

Mermaid diagram (expand to render)

Vimentin is a type III intermediate filament protein encoded by the [VIM](/proteins/vim-protein) gene that serves as a key structural component of the cytoskeleton in various cell types, including [neurons](/entities/neurons) and glial cells. In the central nervous system, vimentin is expressed predominantly in [astrocytes](/cell-types/astrocytes), [microglia](/cell-types/microglia), and neural progenitor cells, with lower expression in mature neurons under normal conditions["@herrmann2007"]. Vimentin plays critical roles in maintaining cellular architecture, facilitating intracellular transport, regulating signal transduction pathways, and responding to cellular stress["@pekny2019"].

The protein is particularly notable for its upregulation in reactive astrocytes (a process termed astrocytosis or glial scarring) in response to neurodegeneration, making it a widely used marker for assessing neuroinflammatory responses in neurodegenerative disease["@shabbir2014"]. Beyond its structural functions, vimentin participates in numerous protein-protein interactions that regulate [apoptosis](/mechanisms/apoptosis), [autophagy](/entities/autophagy), mitochondrial dynamics, and immune responses—all processes central to neurodegeneration["@eriksson2009"].

Structure

Vimentin exhibits the characteristic architecture of type III intermediate filament proteins:

Primary Structure

Length: 466 amino acids
Molecular weight: ~54 kDa
Isoforms: Multiple splice variants exist, including vimentin-v (a shorter variant)

Domain Organization

N-terminal head domain (amino acids 1-96): Non-helical, glycine-rich region containing multiple phosphorylation sites. This domain participates in protein-protein interactions and filament assembly initiation[@snider2011].

Central rod domain (amino acids 97-410): Alpha-helical coiled-coil structure consisting of four conserved helical segments (1A, 1B, 2A, 2B) separated by linker regions (L1, L12, L2). The coiled-coil mediates dimerization and higher-order assembly[@fuchs1994].

C-terminal tail domain (amino acids 411-466): Variable region involved in post-translational modifications and protein interactions. Contains serine/threonine phosphorylation sites that regulate filament dynamics[@inagaki1996].

Quaternary Structure

Vimentin assembles into a hierarchical structure:

Two polypeptides form a coiled-coil dimer (the basic unit)
Two dimers associate to form a tetramer (soluble subunit)
Tetramers assemble into unit-length filaments
Filaments bundle together to form 10nm intermediate filaments

Post-Translational Modifications

Vimentin undergoes extensive post-translational modifications:

Phosphorylation: Multiple serine/threonine kinases (PKC, CaMKII, Aurora B) phosphorylate vimentin, regulating filament disassembly during mitosis and stress responses[@goto1998]
Methylation: Arginine methylation affects protein interactions
Acetylation: Lysine acetylation influences filament stability
SUMOylation: SUMO modification affects subcellular localization

Normal Function

Cytoskeletal Architecture

Vimentin provides mechanical support and maintains cellular integrity:

Forms a dynamic network extending from the nucleus to the plasma membrane
Coordinates organelle positioning, particularly mitochondria
Supports axonal and dendritic structure in neurons
Facilitates cell migration and process extension

Astrocyte Function

In astrocytes, vimentin:

Partners with [GFAP](/genes/gfap) to form intermediate filament networks
Supports astrocyte morphology and process stability
Enables astrocyte migration during development and injury response
Facilitates calcium wave propagation through the astrocyte network

Neural Development

During development, vimentin:

Guides neural crest cell migration
Supports radial glial cell scaffolding for neuronal migration
Enables process outgrowth in developing neurons
Facilitates synapse formation and remodeling

Cellular Homeostasis

Vimentin regulates:

Mitochondrial distribution and quality control: Vimentin cages surround mitochondria, facilitating proper distribution and selective removal of damaged organelles[@tang2019]
[Autophagy](/mechanisms/autophagy-lysosome-neurodegeneration): Interacts with autophagy receptors to facilitate clearance of protein aggregates
[Apoptosis](/mechanisms/apoptosis): Modulates caspase activation and apoptotic signaling
Cell signaling: Serves as scaffold for various signaling pathways (MAPK, PI3K/Akt)

Role in Neurodegenerative Diseases

Alzheimer's Disease

Vimentin pathology in AD is extensive and multifaceted:

Astrocytic Reactivity
Vimentin is dramatically upregulated in reactive astrocytes surrounding [amyloid-beta](/proteins/amyloid-beta) plaques[@kahlson2022]. These vimentin-positive astrocytes exhibit:

Hypertrophic morphology with enlarged processes
Increased [GFAP](/entities/gfap) and vimentin co-expression
Enhanced inflammatory cytokine production

Relationship to Neurofibrillary Tangles

Vimentin can be incorporated into aberrant filamentous structures
Cross-linking with [tau protein](/proteins/tau) may stabilize pathological aggregates
Phosphorylation patterns in vimentin mirror [tau](/proteins/tau) pathology

[Blood-Brain Barrier](/entities/blood-brain-barrier)

Vimentin in astrocyte end-feet contributes to BBB maintenance
Disruption of vimentin networks correlates with BBB leakage in AD
Altered vimentin affects [astrocyte](/cell-types/astrocytes) uptake of [Aβ](/proteins/amyloid-beta)

Parkinson's Disease

Microglial Activation

Vimentin is upregulated in activated [microglia](/cell-types/microglia) in the substantia nigra
Vimentin-positive [microglia](/cell-types/microglia) cluster around dopaminergic neurons
Correlates with disease severity and progression

[Alpha-Synuclein](/proteins/alpha-synuclein) Connection

Vimentin may facilitate [alpha-synuclein](/proteins/alpha-synuclein) aggregation
Interacts with Lewy body structures
May influence prion-like spread of [α-synuclein](/proteins/alpha-synuclein) pathology

Neuroinflammation

Vimentin released from damaged cells acts as DAMP (damage-associated molecular pattern)
Triggers [TLR4](/entities/tlr4)-mediated inflammatory responses
Amplifies microglial activation in a feed-forward manner

Amyotrophic Lateral Sclerosis (ALS)

Astrocytic Dysfunction

Upregulated in astrocytes in ALS models and patients
Contributes to non-cell autonomous neuronal death
Vimentin-positive astrocytes show impaired glutamate uptake

Protein Aggregate Clearance

Vimentin interacts with [TDP-43](/proteins/tdp-43) aggregates (pathological hallmark of ALS)
May sequester clearance machinery
Affects autophagy-lysosomal pathway function

Multiple Sclerosis

Glial Scarring

Vimentin is a major component of the glial scar
Upregulated in reactive astrocytes around demyelinating lesions
Both beneficial (containing inflammation) and detrimental (inhibiting repair) roles

Oligodendrocyte Precursor Cells

Vimentin expressed in OPCs during migration
Necessary for proper OPC differentiation
Dysregulation may impair remyelination

Therapeutic Implications

Biomarker Potential

Vimentin shows promise as a biomarker:

CSF biomarker: Vimentin levels elevated in CSF of AD and PD patients[@olsson2016]
Blood biomarker: Peripheral blood monocyte vimentin expression correlates with disease state
Imaging target: PET ligands targeting vimentin-reactive astrocytes under development

Therapeutic Targets

Reducing Vimentin Expression

Antisense oligonucleotides targeting VIM reduce astrocyte reactivity
CRISPR-based approaches show promise in preclinical models
Must balance beneficial (anti-inflammatory) and detrimental (support deficits) effects

Modifying Post-Translational Modifications

Kinase inhibitors (e.g., PKC inhibitors) reduce vimentin phosphorylation
May decrease astrocyte reactivity and neuroinflammation

Blocking Vimentin Release

Inhibition of vimentin secretion as DAMP
Neutralizing antibodies against extracellular vimentin
Reduces microglial activation

Drug Development

Several strategies are being explored:

Small molecule inhibitors: Targeting vimentin polymerization
Natural compounds: Curcumin and other polyphenols affect vimentin dynamics
Gene therapy: AAV-mediated VIM knockdown in astrocytes

Interactions and Pathways

Protein Interactions

| Partner | Interaction Type | Functional Consequence |
|---------|-----------------|----------------------|
| [GFAP](/genes/gfap) | Heterodimer formation | Astrocyte IF network |
| [Tau](/proteins/tau) | Co-aggregation | NFT formation |
| [α-Synuclein](/proteins/alpha-synuclein) | Binding | Lewy body formation |
| [TDP-43](/proteins/tdp-43) | Co-aggregation | ALS pathology |
| Beclin-1 | Autophagy regulation | Mitophagy |
| Parkin | Mitochondrial quality control | PD pathogenesis |

Signaling Pathways

MAPK/ERK pathway: Vimentin phosphorylation regulates activation
PI3K/Akt: Vimentin scaffold enables downstream signaling
[NF-κB](/entities/nf-kb): Vimentin supports inflammatory gene expression
JNK/c-Jun: Stress-activated kinase phosphorylates vimentin

Research Techniques

Detection Methods

Immunohistochemistry: Antibodies against vimentin (clone V9) widely used
Western blot: 57 kDa band detected under reducing conditions
ELISA: Quantifies soluble vimentin in biofluids
PET imaging: Novel tracers for reactive astrocytes

Model Systems

Vimentin knockout mice: Viable and fertile, but show wound healing deficits
Transgenic models: Human VIM overexpression under astrocyte promoters
iPSC-derived astrocytes: Patient-specific models for disease modeling

Background

The study of Cerebral Glucose Hypometabolism In Neurodegeneration has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.

Pathway Diagram

The following diagram shows the key molecular relationships involving Cerebral Glucose Hypometabolism in Neurodegeneration discovered through SciDEX knowledge graph analysis:

Mermaid diagram (expand to render)

📖 View canonical wiki page →

Cerebral Glucose Hypometabolism in Neurodegeneration

VIM Protein (Vimentin)

Introduction

Overview

VIM Protein (Vimentin)

Introduction

Overview

Structure

Primary Structure

Domain Organization

Quaternary Structure

Post-Translational Modifications

Normal Function

Cytoskeletal Architecture

Astrocyte Function

Neural Development

Cellular Homeostasis

Role in Neurodegenerative Diseases

Alzheimer's Disease

Parkinson's Disease

Amyotrophic Lateral Sclerosis (ALS)

Multiple Sclerosis

Therapeutic Implications

Biomarker Potential

Therapeutic Targets

Drug Development

Interactions and Pathways

Protein Interactions

Signaling Pathways

Research Techniques

Detection Methods

Model Systems

Background

See Also

Pathway Diagram